Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

Diabetologia

Volumn 38, Issue 3, 1995, Pages 337-343

  Dinneen, S ^a   Alzaid, A ^a   Turk, D ^a   Rizza, R ^a  

^a MAYO CLINIC   (United States)

Author keywords

glucose glucose 6 phosphate cycling; hepatic glucose cycling; Hepatic glucose release; insulin dependent diabetes mellitus

Indexed keywords

GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOSTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CARBON RADIOISOTOPES; DIABETES MELLITUS, INSULIN-DEPENDENT; DIETARY CARBOHYDRATES; EATING; FEMALE; GLUCAGON; GLUCOSE; HUMAN; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; INSULIN; KINETICS; LIVER; MALE; PORTAL SYSTEM; RADIOISOTOPE DILUTION TECHNIQUE; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TRITIUM;

EID: 0028883204     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00400639     Document Type: Article

References (34)

1. Role of glucagon in the pathogenesis of diabetes: the status of the controversy
2. Glucagon and diabetes: a reappraisal
3. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo
4. Importance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs
5. Hormonal control of substrate cycling in humans
6. The control of glycogen metabolism in the liver
7. Lack of a role for glucagon in the disposal of an oral glucose load in normal man
8. The effect of intraportal and peripheral infusions of glucagon on insulin and glucose concentrations and glucose tolerance in normal man
9. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects
10. Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetes
11. Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin
12. Specificity, temporal relationships, and quantitative aspects
13. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients
14. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans
15. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics
16. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus
17. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration
18. A simplified, colorimetric micromethod for xylose in serum or urine with phloroglucinol
19. Assessment of insulin action in insulin-dependent diabetes mellitus using [6-14C]glucose, [3-3H]glucose, and [2-3H]glucose. Differences in the apparent pattern of insulin resistance depending on the isotope used
20. Measurement of size and turnover rate of body glucose pool by the isotope dilution method
21. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man
22. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man
23. Glucagon-stimulated glycogenolysis: time-dependent sensitivity to insulin
24. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog
25. Persistent effect of sustained hyperglucagonemia on glucose production in man
26. Evidence for an important role of changes in, rather than absolute concentrations of, glucagon in the regulation of glucose production in humans
27. Futile cycles in the metabolism of glucose
28. Testing of the assumptions made in estimating the extent of futile cycling
29. Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes
30. Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver
31. Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions
32. Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon
33. Effects of pulsatile delivery of insulin and glucagon in humans
34. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man